Entropy Neurodynamics (TYPTF) Stock Price, Quote, News & History

Entropy Neurodynamics Ltd (TYPTF) Stock Price, Quote, News & History

TYPTFOTCPK

Trade with Public

Price data is not available

Key Statistics

Open

Volume / Avg.

95.00K / 99.82K

Day Range

- - -

52 Wk Range

0.01 - 0.03

Market Cap

$21.02M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Entropy Neurodynamics News

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials

Tryptamine Therapeutics advances TRP-8803, an IV psilocin therapy with rapid onset and enhanced safety, to Phase 2 clinical trials.

Juan Spínelli

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-15.46K

Financing Cash Flow (TTM)

9.04M

Free Cash Flow (TTM)

-5.35M

Capital Expenditure (TTM)

-15.46K

Net Change in Cash (TTM)

3.69M

Valuation Metrics

Enterprise Value

$30.10M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

3.74

Earnings Yield % (TTM)

-14.70%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.03M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

95.00K / 99.82K

Day Range

- - -

52 Wk Range

0.01 - 0.03

Market Cap

$21.02M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's l...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entropy Neurodynamics (TYPTF) stock?

You can purchase shares of Entropy Neurodynamics (OTCPK:TYPTF) through any online brokerage.

View our list of the best stock brokerages

Who are Entropy Neurodynamics (TYPTF) competitors?

There are no as such competitors for Entropy Neurodynamics.

What is the forecast, or price target, for Entropy Neurodynamics (TYPTF) stock?

There is no analysis for Entropy Neurodynamics to provide a consensus price target.

What is the current price for Entropy Neurodynamics (TYPTF)?

The stock price for Entropy Neurodynamics (OTCPK: TYPTF) is $ last updated .

Does Entropy Neurodynamics (TYPTF) pay a dividend?

There are no upcoming dividends for Entropy Neurodynamics.

When is Entropy Neurodynamics (OTCPK:TYPTF) reporting earnings?

Entropy Neurodynamics does not have any upcoming earnings scheduled.

Is Entropy Neurodynamics (TYPTF) going to split?

There is no upcoming split for Entropy Neurodynamics.

What sector and industry does Entropy Neurodynamics (TYPTF) operate in?

Entropy Neurodynamics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.

Key Statistics

Open

Volume / Avg.

95.00K / 99.82K

Day Range

- - -

52 Wk Range

0.01 - 0.03

Market Cap

$21.02M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Entropy Neurodynamics News

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials

Tryptamine Therapeutics advances TRP-8803, an IV psilocin therapy with rapid onset and enhanced safety, to Phase 2 clinical trials.

Juan Spínelli

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-15.46K

Financing Cash Flow (TTM)

9.04M

Free Cash Flow (TTM)

-5.35M

Capital Expenditure (TTM)

-15.46K

Net Change in Cash (TTM)

3.69M

Valuation Metrics

Enterprise Value

$30.10M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

3.74

Earnings Yield % (TTM)

-14.70%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.03M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

95.00K / 99.82K

Day Range

- - -

52 Wk Range

0.01 - 0.03

Market Cap

$21.02M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entropy Neurodynamics (TYPTF) stock?

You can purchase shares of Entropy Neurodynamics (OTCPK:TYPTF) through any online brokerage.

View our list of the best stock brokerages

Who are Entropy Neurodynamics (TYPTF) competitors?

There are no as such competitors for Entropy Neurodynamics.

What is the forecast, or price target, for Entropy Neurodynamics (TYPTF) stock?

There is no analysis for Entropy Neurodynamics to provide a consensus price target.

What is the current price for Entropy Neurodynamics (TYPTF)?

The stock price for Entropy Neurodynamics (OTCPK: TYPTF) is $ last updated .

Does Entropy Neurodynamics (TYPTF) pay a dividend?

There are no upcoming dividends for Entropy Neurodynamics.

When is Entropy Neurodynamics (OTCPK:TYPTF) reporting earnings?

Entropy Neurodynamics does not have any upcoming earnings scheduled.

Is Entropy Neurodynamics (TYPTF) going to split?

There is no upcoming split for Entropy Neurodynamics.

What sector and industry does Entropy Neurodynamics (TYPTF) operate in?

Entropy Neurodynamics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.